Ismail Kasujee

Longterm clinical outcomes of omalizumab therapy in severe allergic asthma: Study of efficacy and safety

Adel Mansur, Sapna Srivastava, V Mitchell et al. · Respiratory Medicine · 2017 · 77 citations · Full text

Life Sciences, Immunology, Pharmacology +16

Still Fighting for Breath: a patient survey of the challenges and impact of severe asthma

Paraskevi Κatsaounou, Mikaëla Odemyr, Otto Spranger et al. · ERJ Open Research · 2018 · 35 citations · Full text

Public Health, Chronic Disease Control, Health Sciences +14

Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1‐antihistamine treatment: results of the phase <scp>IV</scp> open‐label <scp>SUNRISE</scp> study

F. Bérard, M.C. Ferrier Le Bouëdec, Laurence Bouillet et al. · British Journal of Dermatology · 2018 · 33 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +13

Tildrakizumab improves high burden skin symptoms, impaired sleep and quality of life of moderate‐to‐severe plaque psoriasis patients in conditions close to clinical practice

Antonio Costanzo, Mar Llamas‐Velasco, Gabriella Fabbrocini et al. · Journal of the European Academy of Dermatology and Venereology · 2023 · 27 citations · Full text

Medicine, Dermatology, Pharmacotherapy +16

A Retrospective Real-World Study of the Effectiveness and Tolerability of Tildrakizumab in UK Adults with Moderate-to-Severe Chronic Plaque Psoriasis

G Becher, Sophia Conner, Jennifer A. Ingram et al. · Dermatology and Therapy · 2022 · 23 citations · Full text

Medicine, Dermatology, Pharmacotherapy +10